Status:
COMPLETED
Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.
Lead Sponsor:
Cairo University
Conditions:
Infertility
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
210 women with clomiphene resistant PCOS will be randomly divided into 3 equal groups using computer generated random numbers. Group 1 will receive FSH, group 2 will have Letrozole and group 3 will ac...
Detailed Description
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age, with an incidence of 5 -10%. Classically clomiphene citrate (CC) is the first approach to induce ovulation i...
Eligibility Criteria
Inclusion
- Clomiphene resistant PCOS.
Exclusion
- Other causes of infertility.
- Hyperprolactinaemia.
- Allergy to Letrozole or FSH.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT02304107
Start Date
May 1 2013
End Date
January 1 2015
Last Update
July 6 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BeniSuef University hospitals
BeniSuef, Egypt
2
Cairo University Hospitals
Cairo, Egypt